Transcend Capital Advisors, LLC Rx Sight, Inc. Transaction History
Transcend Capital Advisors, LLC
- $1.35 Billion
- Q2 2024
A detailed history of Transcend Capital Advisors, LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 16,835 shares of RXST stock, worth $832,154. This represents 0.08% of its overall portfolio holdings.
Number of Shares
16,835
Previous 17,120
1.66%
Holding current value
$832,154
Previous $883,000
14.61%
% of portfolio
0.08%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding RXST
# of Institutions
233Shares Held
31.4MCall Options Held
57.8KPut Options Held
12.5K-
Ra Capital Management, L.P. Boston, MA3.69MShares$183 Million3.35% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$119 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.01MShares$99.3 Million0.0% of portfolio
-
Lord, Abbett & Co. LLC Jersey City, NJ1.74MShares$85.8 Million0.35% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.33MShares$65.9 Million0.13% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $1.37B
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...